These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1290721)

  • 21. Melphalan-induced appearance of potent antitumor immune reactivity in tumor bearer lymphocytes co-expressing the Lyt 2 and the L3T4 antigens.
    Takesue BY; Bartik MM; Mokyr MB
    Int J Immunopharmacol; 1987; 9(6):705-17. PubMed ID: 2891627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.
    Kohya H; Ebina T; Yamaguchi T; Ishida N
    Biotherapy; 1989; 1(3):139-51. PubMed ID: 2534966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differences in antitumor effect of various BRMs by intratumoral administration: induction of immunosuppressive acidic protein].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1453-6. PubMed ID: 8373204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competitive action of a biological response modifier, PSK, on a humoral immunosuppressive factor produced in tumor-bearing hosts.
    Matsunaga K; Morita I; Iijima H; Endo H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1990 Mar; 31(3):127-36. PubMed ID: 1966997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of a protein-bound polysaccharide, PSK, on CLP-induced sepsis in mice transplanted orthotopically with colon tumor.
    Ohmura Y; Matsunaga K; Suzuki T
    Shock; 2006 Jan; 25(1):36-42. PubMed ID: 16369184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a biological response modifier, PSK, on intestinal flora of tumor-bearing mice.
    Sakurai K; Motokawa I; Ando T; Ohmura Y; Saito K; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
    In Vivo; 1993; 7(2):175-9. PubMed ID: 8364170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in vivo study of hepatic and splenic interleukin-1 beta mRNA expression following oral PSK or LEM administration.
    Morinaga H; Tazawa K; Tagoh H; Muraguchi A; Fujimaki M
    Jpn J Cancer Res; 1994 Dec; 85(12):1298-303. PubMed ID: 7852192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of PSK on tumor-specific immunity induced by MMC-treated syngeneic tumor cells].
    Tsuru S; Oguchi M; Mashiko M; Aiso S; Zinnaka Y; Nomoto K
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1634-9. PubMed ID: 6820923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of PSK on the recovery of macrophage function in tumor-bearing mice].
    Ando T; Mastuda Y; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):827-34. PubMed ID: 6721504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regional adoptive immunotherapy using activated lymphocytes].
    Ebina T; Isono N; Murata K; Yokoyama J; Mikuni J; Ohuchi K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1549-52. PubMed ID: 8854802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intratumoral administration of biological preparations--recommendation for integrative medicine].
    Ebina T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1515-8. PubMed ID: 11707968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of macrophage activity in tumor bearing mice by cytogenin.
    Kumagai H; Masuda T; Sakashita M; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1995 Apr; 48(4):321-5. PubMed ID: 7775270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a mouse serum protein increased by administration of an antitumor polysaccharide, PSK, as a variant of mouse transferrin and some of its biological activities.
    Kojima E; Mitsuno T; Osawa T
    J Pharmacobiodyn; 1986 Feb; 9(2):174-81. PubMed ID: 3712215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Competitive effect of PSK against the immunosuppressive effect induced in the sera of mice bearing syngeneic tumors].
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3461-7. PubMed ID: 3789757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
    Algarra I; Collado A; Garrido F
    J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of pretreatment with lentinan or krestin on antitumor effector cell activities suppressed by cyclophosphamide].
    Yang ZB
    Hokkaido Igaku Zasshi; 1994 Jan; 69(1):137-45. PubMed ID: 8119654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells.
    Hirose K; Zachariae CO; Oppenheim JJ; Matsushima K
    Lymphokine Res; 1990; 9(4):475-83. PubMed ID: 2090874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effect of intratumoral administration of biological response modifiers: induction of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in mice.
    Ebina T; Murata K; Tamura K
    Jpn J Cancer Res; 1994 Jan; 85(1):93-100. PubMed ID: 8106294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice.
    Ebina T; Fujimiya Y
    Biotherapy; 1998; 11(4):259-65. PubMed ID: 9950102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antitumor effect of intratumoral administration of BRM: inhibition of tumor cell invasion in vitro].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1626-8. PubMed ID: 7574777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.